Thermo Fisher Scientific Life Sciences Solutions — Research and development expenses decreased by 3.5% to $136.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 3.5%, from $141.00M to $136.00M. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher spending indicates a commitment to innovation, which is vital for long-term growth in the life sciences sector.
Expenditures dedicated to the discovery and development of new products, technologies, and scientific solutions within t...
Benchmark for innovation-driven companies in the life sciences and technology sectors.
tmo_segment_life_sciences_solutions_research_and_development_expenses| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q3 '24 | Q3 '25 | |
|---|---|---|---|---|---|---|
| Value | $139.50M | $139.50M | $139.50M | $139.50M | $141.00M | $136.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +1.1% | -3.5% |
| YoY Change | — | — | — | — | +1.1% | -3.5% |
We use cookies for analytics. See our Privacy and Cookie Policy.